Psyence Biomedical PBM
NASDAQ PBM
$4.87 +0.03 (+0.62%)
As of: Sep 10, 2026 · 11:43 AM EDT

Psyence Biomedical (PBM) Interest Coverage Ratio (2023 - 2025)

Psyence Biomedical (PBM) posted Interest Coverage Ratio of 547.67 for Q3 2025, up 75.42% on a QoQ basis from 312.2 in Q3 2024, and up 75.42% year-over-year from 312.2 in Q3 2024.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Psyence Biomedical (PBM) Interest Coverage Ratio (2023 - 2025) Analysis & Trends

Psyence Biomedical has reported Interest Coverage Ratio for 3 years, with the latest figure at 547.67 in Q3 2025.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Amgen 206.86 Bn 192.87 Bn 7.24 Bn 5.22
2 Gilead Sciences 179.52 Bn 176.34 Bn 6.22 Bn -42.08
3 Vertex Pharmaceuticals 131.47 Bn 123.62 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 117.59
5 Argenx Se 61.16 Bn 55.98 Bn 1.37 Bn 493.00
6 Moderna 53.15 Bn 48.02 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.20 Bn 29.89 Bn 992.69 Mn 2.82
8 Biogen 31.65 Bn 30.37 Bn 1.96 Bn -
9 Roivant Sciences 29.30 Bn 29.30 Bn 1.16 Mn -
10 Psyence Biomedical 2.63 Mn 2.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 547.67
Sep 30, 2024 312.20
Sep 30, 2023 -7.30